Does IFOSFAMIDE Cause Diffuse large b-cell lymphoma recurrent? 232 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 232 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with IFOSFAMIDE (IFEX). This represents 1.4% of all adverse event reports for IFOSFAMIDE.
232
Reports of Diffuse large b-cell lymphoma recurrent with IFOSFAMIDE
1.4%
of all IFOSFAMIDE reports
47
Deaths
52
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From IFOSFAMIDE?
Of the 232 reports, 47 (20.3%) resulted in death, 52 (22.4%) required hospitalization, and 13 (5.6%) were considered life-threatening.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IFOSFAMIDE. However, 232 reports have been filed with the FAERS database.
What Other Side Effects Does IFOSFAMIDE Cause?
Off label use (2,281)
Febrile neutropenia (2,225)
Disease progression (1,912)
Neutropenia (1,509)
Drug ineffective (1,331)
Thrombocytopenia (1,227)
Anaemia (1,067)
Product use in unapproved indication (890)
Pyrexia (752)
Sepsis (712)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which IFOSFAMIDE Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
IFOSFAMIDE vs IGURATIMOD
IFOSFAMIDE vs ILOPERIDONE
IFOSFAMIDE vs ILOPROST
IFOSFAMIDE vs IMATINIB
IFOSFAMIDE vs IMBRUVICA